SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MLTX is trending due to discussion around mixed Phase 3 trial data for their skin disease drug, with community members debating the severity of the results and potential for a rebound. Some believe the selloff is an overreaction, citing the company's cash position and institutional ownership, while others point to concerns about the drug's efficacy compared to competitors. Speculation about a potential Merck buyout continues to fuel some of the interest.

Dogwood Therapeutics, Inc. is a development-stage biotechnology company, which engages in developing therapeutics for pain and fatigue illness. Its product includes Halneuron. It focuses on antiviral therapies IMC-1 and IMC-2 to treat diseases associated with a viral triggered abnormal immune response such as Long-COVID and fibromyalgia. The company was founded on February 28, 2012 is headquartered in Alpharetta, GA.

Dogwood Therapeutics Inc.

Dogwood Therapeutics is trending as traders discuss its recent exclusive worldwide license for a cancer pain treatment, with many highlighting its low float and potential for a short squeeze. The community is actively speculating on price targets and anticipating further volatility, focusing on potential breakout levels. Some traders cite upcoming catalysts, including Fibromyalgia/partnership news late in Q4.

SPDR Gold Trust - SPDR Gold Shares ETF

SPDR Gold Shares ETF

GLD is trending as gold prices rally, fueled by anticipation of Federal Reserve rate cuts and safe-haven demand amidst global economic and political uncertainty. Community members are actively discussing whether the current rally is sustainable, with some pointing to overbought conditions and potential pullbacks, while others remain bullish due to the weakening dollar and central bank activity. Broader market context includes discussions around inflation, currency devaluation, and comparisons to other asset classes like Bitcoin.

A project grown out of the community's love and passion for the weed culture. Launched around early 2025, $weedcoin, “Like Bitcoin but way higher,” emphasizes its alignment with cannabis culture and a laid-back vibe. Unlike other Weed communities, this project leans heavily into community engagement over technical utility, aiming to build a “stoner community” through social media presence and decentralized governance. We also aim to focus on onboarding web2 businesses and users onto web3 through the token.

Weedcoin

Weedcoin is trending as a community-driven token focused on culture, freedom, and growth within the cannabis space. The community emphasizes positivity and connection through the Weedcoin movement, highlighting its aim to bridge culture and currency. Discussions also reference potential catalysts for the cannabis sector, further fueling interest in Weedcoin.

Kala Bio, Inc. is a biopharmaceutical company. It focuses on the development and commercialization of therapeutics using proprietary nanoparticle-based mucus penetrating particles with an initial focus on the treatment of eye diseases. The company was founded by Justin Hanes, Robert S. Langer and Colin R. Gardner in 2009 and is headquartered in Arlington, MA.

Kala Bio Inc.

Kala Pharmaceuticals Inc

Kala Pharmaceuticals is trending due to a trading halt and news regarding its CHASE Phase 2b KPI-012 trial failing to meet the primary endpoint, sparking community discussion around shorting opportunities and the future of the company; community members are discussing the potential for a significant drop, given the company's single-product focus.

Larimar Therapeutics, Inc. Is a clinical-stage biopharmaceutical company, which engages in the research, development, and commercialization of novel therapeutics mitochondrial disorders and Friedreich's ataxia. The company was founded in 2005 and is headquartered in Bala Cynwyd, PA.

Larimar Therapeutics Inc

Larimar Therapeutics is trending due to positive data from its Friedreich's Ataxia study, although concerns linger about anaphylaxis rates. The community is debating the market's reaction, with some seeing a buying opportunity amidst the sell-off, while others remain cautious about the drug's safety profile. Long-term bulls highlight the potential for a short squeeze, insider buying, and the drug's ability to address the underlying cause of the disease.

Electronic Arts, Inc. engages in the development, marketing, publication, and distribution of games, content, and services for game consoles, PCs, mobile phones, and tablets. The company develops and publishes games and services across various genres, such as sports, first-person shooter, action, role-playing, and simulation primarily under the Battlefield, The Sims, Apex Legends, Anthem, Need for Speed, and Plants v. Zombies brands, and license games, including FIFA, Madden NFL, and Star Wars brands. The firm also provides advertising services and licenses its games to third parties to distribute and host its games. It markets and sells its games and services through digital distribution channels, as well as through retail channels, such as mass-market retailers, electronics specialty stores, and game software specialty stores. The company was founded by William M. Hawkins III and William Gordon in 1982 and is headquartered in Redwood City, CA.

Electronic Arts, Inc.

Electronic Arts is trending due to reports of a potential $50 billion privatization deal, which sent the stock surging. The community is actively discussing the buyout price and potential impact on current shareholders. Some are also speculating about the future direction of the company and its games should the deal go through.

JFB Construction Holdings is a commercial and residential real estate construction and development company, which engages in delivering services to commercial and residential markets. It operates through the following segments: Commercial Construction, Residential Construction, and Real Estate Development. The Commercial Construction segment includes all activities related to the construction of commercial properties. The Residential Construction segment focuses on the construction of residential properties including single-family homes and multi-family units. The Real Estate Development segment refers to the acquisition, development, and sale of real estate properties. The company was founded by Joseph F. Basille III on April 9, 2024 and is headquartered in Lantana, FL.

JFB Construction Holdings - Ordinary Shares - Class A

JFB is trending due to a recently announced $44 million private placement, sparking discussions about its potential impact on the company's liquidity and future prospects. The community is actively debating the merits of the deal, with some focusing on the low float and potential for a squeeze, while others express concern about possible dilution. Breakout levels are being closely watched as the stock experiences high volume and volatility.

USA Rare Earth, Inc. is domestic supplier of rare earth magnets and heavy rare earth elements. It is developing a vertically integrated, domestic supply chain for rare earth element magnet production, with a facility in Stillwater, Oklahoma, and mining rights to the Round Top heavy rare earth and critical minerals deposit in West Texas. The company was founded in May 2019 and is headquartered in Stillwater, OK.

USA Rare Earth Inc. - Ordinary Shares - Class A

USA Rare Earth Inc

USA Rare Earth is trending due to its acquisition of a UK rare earth metals producer, sparking bullish sentiment and discussions about potential price targets. The community is actively debating the significance of this expansion and whether it can push the stock to new all-time highs. Broader discussions touch on the strategic importance of rare earth minerals and potential government support for domestic suppliers.

"What's Updog?" is a Community Led token.

UpDog

UpDog is trending as the community rallies around the joke-inspired memecoin on the Solana network, celebrating its locked liquidity pool and long-term presence on the $JUP.X strict list. Community members are actively engaging with the UpDog meme, while also highlighting notable holders and encouraging others to load up on the token.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

The Zacks Analyst Blog Highlights Heritage Insurance, ProAssurance and HCI

Heritage Insurance, ProAssurance, and HCI Group have each surged over 25% YTD, powered by strong underwriting, pricing gains, and growth in niche P&C markets.

3 P&C Insurance Stocks That Have Rallied More Than 25% YTD

Despite higher catastrophe losses, HRTG, PRA, and HCI not only outperform the industry but also crush the Zacks S&P 500 composite and Finance sector.

Can UnitedHealth Really Fight Cost Headaches With $3.3B Amedisys Pill?

UNH's $3.3B Amedisys deal will likely clear DOJ hurdles with divestitures, aiming to tap fast-growing home healthcare amid rising cost pressures.

ProAssurance Q2 Earnings Beat Estimates on Declining Expenses

PRA's Q2 earnings top estimates as lower expenses and higher investment income offset weaker premiums.

ProAssurance (PRA) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

Although the revenue and EPS for ProAssurance (PRA) give a sense of how its business performed in the quarter ended June 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

ProAssurance (PRA) Surpasses Q2 Earnings and Revenue Estimates

ProAssurance (PRA) delivered earnings and revenue surprises of +173.68% and +1.96%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Are Options Traders Betting on a Big Move in ProAssurance Stock?

Investors need to pay close attention to ProAssurance stock based on the movements in the options market lately.

ProAssurance (PRA) Up 0.8% Since Last Earnings Report: Can It Continue?

Is Invesco S&P SmallCap 600 Pure Value ETF (RZV) a Strong ETF Right Now?

Should Invesco S&P SmallCap 600 Pure Value ETF (RZV) Be on Your Investing Radar?

ProAssurance Corp. is a holding company that engages in specialty insurance, providing medical professional liability, product liability for medical technology and life sciences. It operates through the following segments: Specialty Property and Casualty, Workers' Compensation Insurance, Lloyd's Syndicate, Segregated Portfolio Cell Reinsurance and Corporate. The Specialty Property and Casualty segment includes professional liability business and medical technology and life sciences business. The Workers' Compensation Insurance segment includes the workers' compensation business which the company provides for employers, groups and associations. The Lloyd's Syndicate segment includes operating results from participation in Lloyd's Syndicate 1729. The Segregated Portfolio Cell Reinsurance segment assumes workers' compensation insurance, healthcare professional liability insurance or a combination of the two from Workers' Compensation Insurance and Specialty Property & Casualty segments. The Corporate segment includes investing operations managed at the corporate level, non-premium revenues generated outside of insurance entities, and corporate expenses, including interest and U.S. income taxes. The company was founded in 1976 and is headquartered in Birmingham, AL.

Proassurance Corporation

Will the U.S. government shut down in 2025? 
 
*Powered by Polymarket

Fiscal Period	Estimated	Reported	Surprise	Result
Q3 '25	$0.26	--	--	N/A
Q2 '25	$0.21	$0.52	148.21%	BEAT
Q1 '25	$0.20	$0.13	-33.89%	MISSED
Q4 '24	$0.17	$0.36	113.90%	BEAT
Q3 '24	$0.14	$0.34	141.13%	BEAT

PRA
Proassurance Corporation

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q3 '25

Historical Earnings

Latest PRA News

PRA Proassurance Corporation